Regenxbio Inc (RGNX) financials · rev $170.4M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Regenxbio Inc (RGNX) rev $170.4M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $170.4M | $83.3M |
| Cost of Revenue | N/A | $33.6M |
| Gross Profit | N/A | $49.8M |
| Operating Income | -$161.2M | -$233.3M |
| Net Income | -$193.9M | -$227.1M |
| EPS (Diluted) | -$3.76 | -$4.59 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $453.0M | $466.0M |
| Current Assets | $281.3M | $278.0M |
| Cash & Equivalents | $34.5M | $57.5M |
| PP&E | $104.9M | $117.6M |
| Total Liabilities | $350.3M | $206.3M |
| Current Liabilities | $118.1M | $103.2M |
| Shareholders' Equity | $102.7M | $259.7M |
| Retained Earnings | -$1.13B | -$932.1M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$124.0M | -$173.1M |
| CapEx | $2.41M | $2.44M |
| Investing Cash Flow | -$15.9M | $103.4M |
| Financing Cash Flow | $116.8M | $92.7M |
| Net Change in Cash | -$23.1M | $23.0M |
| Free Cash Flow | -$126.4M | -$175.6M |
FAQ
What is RGNX P/E and revenue?
Regenxbio Inc (RGNX) rev $170.4M.
What is RGNX revenue?
Regenxbio Inc last cached revenue is $170.4M (FY2025).
Is RGNX profitable?
Regenxbio Inc last cached net income is -$193.9M (FY2025).
What are RGNX total assets?
Regenxbio Inc last cached total assets are $453.0M (FY2025).
What is RGNX free cash flow?
Regenxbio Inc last cached free cash flow is -$126.4M (FY2025).
Not investment advice. Cached statements, not a live tape.